The UK Monarch has been quietly battling prostate cancer while also fulfilling his duties as King, and apparently there's ...
Virginia Mason Franciscan Health's "Crucial Catch" offers walk-up screenings for prostate, lung and colorectal cancer at ...
Researchers at the University of Michigan have discovered a powerful new way to stop prostate cancer from growing—by ...
The phase 3 PSMAddition trial demonstrated that the radioligand therapy Lutetium-177 PSMA-617 (Pluvicto) provides a ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Among patients with prostate cancer with homologous recombination repair mutations (HRRm) receiving Akeega (niraparib and ...
In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.
McGeechan shared his diagnosis in May and underwent treatment, which included a six-week course of radiotherapy ...
Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...
WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...
Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...
IS THE PRINCIPAL INVESTIGATOR IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PA / ACCESS Newswire / / Medicus Pharma Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback